Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | RARB | P10826 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1954568 | 1.00 | TSHR (0.57) | TSHRCYP3A4MEN1THRBHTT | |
| SCHEMBL273578 | 1.00 | TSHR (0.57) | TSHRCYP3A4MEN1THRBHTT | |
| SCHEMBL3695089 | 1.00 | TSHR (0.57) | TSHRCYP3A4MEN1THRBHTT | |
| SCHEMBL17394526 | 1.00 | TSHR (0.57) | TSHRCYP3A4MEN1THRBHTT | |
| SCHEMBL2799321 | 1.00 | TSHR (0.57) | TSHRCYP3A4MEN1THRBHTT | |
| SCHEMBL23356864 | 1.00 | TSHR (0.57) | TSHRCYP3A4MEN1THRBHTT | |
| SCHEMBL3838219 | 1.00 | TSHR (0.57) | TSHRCYP3A4MEN1THRBHTT | |
| SCHEMBL15023631 | 1.00 | TSHR (0.57) | TSHRCYP3A4MEN1THRBHTT | |
| SCHEMBL274644 | 1.00 | TSHR (0.57) | TSHRCYP3A4MEN1THRBHTT | |
| Water SCHEMBL28033915 | 0.97 | TSHR (0.55) | TSHRCYP3A4MEN1THRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 653 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250008950-A1 | BIOCIDE COMPOSITIONS | BASF SE (DE) | 2025-01-09 | — | — | US | claimed |
| EP-4440307-A1 | BIOCIDE COMPOSITIONS | BASF SE (DE) | 2024-10-09 | — | — | EP | claimed |
| CN-118338782-A | Biocidal compositions | 巴斯夫欧洲公司 | 2024-07-12 | — | — | CN | claimed |
| US-20240076578-A1 | REDUCED MIST ALKALINE CLEANER VIA THE USE OF ALKALI SOLUBLE EMULSION POLYMERS | ECOLAB USA INC. | 2024-03-07 | — | — | US | claimed |
| CN-117500747-A | System and method for color forming solutions for aqueous structures | 塞浦里斯材料股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| EP-4291524-A1 | SYSTEM AND METHOD FOR AN AQUEOUS STRUCTURAL COLOR FORMING SOLUTION | Cypris Materials Inc. (US) | 2023-12-20 | — | — | EP | claimed |
| US-11834633-B2 | Reduced mist alkaline cleaner via the use of alkali soluble emulsion polymers | ECOLAB USA INC. (US) | 2023-12-05 | — | — | US | claimed |
| US-11773191-B2 | Modification initiator and modified conjugated diene-based polymer including the same | LG CHEM, LTD. | 2023-10-03 | — | — | US | claimed |
| WO-2023099366-A1 | BIOCIDE COMPOSITIONS | BASF SE (DE) | 2023-06-08 | — | — | WO | claimed |
| EP-4171222-A1 | BIOCIDE COMPOSITIONS | BASF SE (DE) | 2023-05-03 | — | — | EP | claimed |
| EP-1453828-A2 | AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME | AstraZeneca AB (SE) | 2004-09-08 | — | — | EP | claimed |
| EP-1453869-A2 | MICROSTRUCTURE MODIFIER FOR ANIONIC POLYMERIZATION | Hellermann, Walter (DE) | 2004-09-08 | — | — | EP | claimed |
| WO-2004072032-A2 | POLYIMIDE FOAMS | UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 2004-08-26 | — | — | WO | claimed |
| CN-1439704-A | Colour cathode-ray tube screeing cleaning material and cleaning method thereof | LG PHILIPS DISPLAYS KOREA (KR) | 2003-09-03 | — | — | CN | claimed |
| WO-2003044065-A2 | MICROSTRUCTURE MODIFIER FOR ANIONIC POLYMERIZATION | HELLERMANN WALTER (DE) | 2003-05-30 | — | — | WO | claimed |
| WO-2003032897-A2 | AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME | ASTRAZENECA AB (SE) | 2003-04-24 | — | — | WO | claimed |
| US-6504063-B2 | Hydrogenation polyol in aqueous solution | KAO CORPORATION (JP) | 2003-01-07 | — | — | US | claimed |
| US-5364551-A | Polymeric thickener to reduce aerosol particle size | ECOLAB INC. (US) | 1994-11-15 | — | — | US | claimed |
| EP-0009503-A1 | TETRACHLOROISOPHTHALONITRILE DISPERSION | DIAMOND SHAMROCK CORPORATION (US) | 1980-04-16 | — | — | EP | claimed |
| WO-1979000654-A1 | TETRACHLOROISOPHTHALONITRILE DISPERSION | DIAMOND SHAMROCK CORP (US) | 1979-09-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773191-B2 | Modification initiator and modified conjugated diene-based polymer including the same | SETDB1, TET1, DNMT1 | TSHR 4674/4885CYP3A4 1510/4885MEN1 209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.